FDA Can Regulate Stem Cell Treatment As Drug, DC Circ. Hears
The U.S. Food and Drug Administration told the D.C. Circuit that Regenerative Sciences LLC's stem cell treatment is a drug and therefore subject to its regulations, saying a lower court had...To view the full article, register now.
Already a subscriber? Click here to view full article